4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0000950170-24-075071
Chief Executive Officer sold 63,358 shares at an average $46.57 ($2,950,518)
- Chief Executive Officer acquired 56,179 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table I: Non-derivative
15 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +16,830 | $14.10 | $237,303 | 101,230 | D |
| 2024-06-14 | Sale : show line 2 in the form 10b5-1 | −16,830 | $50.17 | $844,297 | 84,400 | D |
| 2024-06-14 | Exercise or conversion : show line 3 in the form 10b5-1 | +12,487 | $4.26 | $53,195 | 96,887 | D |
| 2024-06-14 | Sale : show line 4 in the form 10b5-1 | −12,487 | $50.17 | $626,425 | 84,400 | D |
| 2024-06-17 | Exercise or conversion : show line 5 in the form 10b5-1 | +9,333 | $30.00 | $279,990 | 93,733 | D |
| 2024-06-17 | Sale : show line 6 in the form 10b5-1 | −9,333 | $46.02 | $429,507 | 84,400 | D |
| 2024-06-17 | Exercise or conversion : show line 7 in the form 10b5-1 | +1,770 | $4.26 | $7,540 | 86,170 | D |
| 2024-06-17 | Sale : show line 8 in the form 10b5-1 | −1,770 | $46.02 | $81,456 | 84,400 | D |
| Open-market sales · 63,358 sh · avg $46.57 · $2,950,518 | ||||||
Table II: Derivative
7 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-06-14 | Exercise or conversion : show line 16 in the form 10b5-1 Options to purchase common stock | −16,830 | 32,827 | D |
| 2024-06-14 | Exercise or conversion : show line 17 in the form 10b5-1 Options to purchase common stock | −12,487 | 53,831 | D |
| 2024-06-17 | Exercise or conversion : show line 18 in the form 10b5-1 Options to purchase common stock | −9,333 | 11,667 | D |
| 2024-06-17 | Exercise or conversion : show line 19 in the form 10b5-1 Options to purchase common stock | −1,770 | 52,061 | D |
| 2024-06-18 | Exercise or conversion : show line 20 in the form 10b5-1 Options to purchase common stock | −11,667 | 0 | D |
| 2024-06-18 | Exercise or conversion : show line 21 in the form 10b5-1 Options to purchase common stock | −1,770 | 31,057 | D |
| 2024-06-18 | Exercise or conversion : show line 22 in the form 10b5-1 Options to purchase common stock | −2,322 | 49,739 | D |
Loading xslF345X05/ownership.xml…